This Argan Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

JP Morgan analyst Michael Fairbanks upgraded Argan Inc (NYSE: AGX) from Neutral to Overweight, setting a price target of $550, up from its previous close of $410.85. This follows similar upgrades for Phathom Pharmaceuticals Inc and Quanta Services Inc, indicating a positive shift in analyst sentiment towards these companies. The upgrades reflect a broader trend of increased confidence in the respective stocks.